WEGENERS GRANULOMATOSIS AND ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES

被引:3
|
作者
BATSAKIS, JG
ELNAGGAR, AK
机构
[1] Department of Pathology, The University of Texas M. D., Anderson Cancer Center, Houston, Texas
来源
关键词
D O I
10.1177/000348949310201117
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Serologic tests for antineutrophil cytoplasmic autoantibodies can serve as markers fora number of necrotizing vasculitides and other inflammatory disorders. In the case of Wegener's granulomatosis, an immunofluorescent cytoplasmic pattern and immunoassay for proteinase 3 are quite specific for the disease and are capable of serving as additional criteria for diagnosis. As with any laboratory test, however, results are to be interpreted in the whole clinical and pathologic framework of the disease.
引用
收藏
页码:906 / 908
页数:3
相关论文
共 50 条
  • [31] IS TOLOSA-HUNT SYNDROME A LIMITED FORM OF WEGENERS GRANULOMATOSIS - REPORT OF 2 CASES WITH ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES
    MONTECUCCO, C
    CAPORALI, R
    PACCHETTI, C
    TURLA, M
    BRITISH JOURNAL OF RHEUMATOLOGY, 1993, 32 (07): : 640 - 641
  • [32] ANTINEUTROPHIL-CYTOPLASMIC ANTIBODIES AND ANTIGLOMERULAR BASEMENT-MEMBRANE ANTIBODIES IN GOODPASTURES-SYNDROME AND IN WEGENERS GRANULOMATOSIS
    WEBER, MFA
    ANDRASSY, K
    PULLIG, O
    KODERISCH, J
    NETZER, K
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1992, 2 (07): : 1227 - 1234
  • [33] INFLUENCE OF DISEASE MANIFESTATION AND ANTINEUTROPHIL CYTOPLASMIC ANTIBODY TITER ON THE RESPONSE TO PULSE CYCLOPHOSPHAMIDE THERAPY IN PATIENTS WITH WEGENERS GRANULOMATOSIS
    REINHOLDKELLER, E
    KEKOW, J
    SCHNABEL, A
    SCHMITT, WH
    HELLER, M
    BEIGEL, A
    DUNCKER, G
    GROSS, WL
    ARTHRITIS AND RHEUMATISM, 1994, 37 (06): : 919 - 924
  • [34] TRIMETHOPRIM SULFAMETHOXAZOLE FOR SCLERITIS ASSOCIATED WITH LIMITED WEGENERS GRANULOMATOSIS - USE OF HISTOPATHOLOGY AND ANTINEUTROPHIL CYTOPLASMIC ANTIBODY (ANCA) TEST
    SOUKIASIAN, SH
    JAKOBIEC, FA
    NILES, JL
    PAVANLANGSTON, D
    CORNEA, 1993, 12 (02) : 174 - 180
  • [35] Treatment of vascularides with antineutrophil cytoplasmic autoantibodies
    Esnault, VLM
    PRESSE MEDICALE, 2001, 30 (22): : 1122 - 1125
  • [36] RECOGNITION AND SIGNIFICANCE OF ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES
    MEYER, O
    PRESSE MEDICALE, 1992, 21 (29): : 1361 - 1363
  • [37] ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES - IMMUNOBIOLOGICAL ASPECTS
    GROSS, WL
    CSERNOK, E
    SCHMITT, WH
    KLINISCHE WOCHENSCHRIFT, 1991, 69 (13): : 558 - 566
  • [38] Antineutrophil cytoplasmic autoantibodies in leprosy.
    Medina, F
    Camargo, A
    Moreno, J
    ZonanaNacach, A
    AcevesAvila, J
    Fraga, A
    ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 687 - 687
  • [39] THE PATHOGENIC ROLE OF ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES
    EWERT, BH
    JENNETTE, JC
    FALK, RJ
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1991, 18 (02) : 188 - 195
  • [40] HOW ARE ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES DETECTED
    WIESLANDER, J
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1991, 18 (02) : 154 - 158